[go: up one dir, main page]

FI981381L - Method for producing HCV polypeptides - Google Patents

Method for producing HCV polypeptides Download PDF

Info

Publication number
FI981381L
FI981381L FI981381A FI981381A FI981381L FI 981381 L FI981381 L FI 981381L FI 981381 A FI981381 A FI 981381A FI 981381 A FI981381 A FI 981381A FI 981381 L FI981381 L FI 981381L
Authority
FI
Finland
Prior art keywords
virus
polypeptides
hcv
hcv polypeptides
publication
Prior art date
Application number
FI981381A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI105046B (en
FI981381A0 (en
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of FI981381A0 publication Critical patent/FI981381A0/en
Priority claimed from PCT/US1990/001348 external-priority patent/WO1990011089A1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of FI981381L publication Critical patent/FI981381L/en
Application granted granted Critical
Publication of FI105046B publication Critical patent/FI105046B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The applicant has isolated a virus, hepatitis C virus (HCV), which has been shown to be the primary causative agent of blood-borne NANBH. Original work relating to this virus, which work contains a partial genome sequence of a prototype HCV isolate, has been disclosed in EP publication no. 318 216 and in PCT publication no. WO89/4669. The present invention, which is partially based on novel HCV sequences and polypeptides not presented in said publications, discloses processes for the manufacture of polypeptides and necessary recombinant vectors.
FI981381A 1989-03-17 1998-06-15 Method for Preparation of a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell FI105046B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32533889A 1989-03-17 1989-03-17
US32533889 1989-03-17
US9001348 1990-03-15
PCT/US1990/001348 WO1990011089A1 (en) 1989-03-17 1990-03-15 Nanbv diagnostics and vaccines

Publications (3)

Publication Number Publication Date
FI981381A0 FI981381A0 (en) 1990-03-15
FI981381L true FI981381L (en) 1998-06-15
FI105046B FI105046B (en) 2000-05-31

Family

ID=23267470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981381A FI105046B (en) 1989-03-17 1998-06-15 Method for Preparation of a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell

Country Status (3)

Country Link
DD (1) DD297446A5 (en)
FI (1) FI105046B (en)
RU (1) RU2204603C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent

Also Published As

Publication number Publication date
DD297446A5 (en) 1992-01-09
FI105046B (en) 2000-05-31
FI981381A0 (en) 1990-03-15
RU2204603C2 (en) 2003-05-20

Similar Documents

Publication Publication Date Title
DK0419182T4 (en) New HCV isolate J 1
US5597691C1 (en) Hepatitus c virus protease
EP0484787A3 (en) Hcv-specific peptides, process for obtaining them and their use
PT725824E (en) HEPATITIS C VIRUS IMMUNODOMINANT HUMAN T-CELL EPITOPS
CA2012482A1 (en) Hepatitis c diagnostics and vaccines
AU2197392A (en) Hepatitis C virus from C-100-3 and env/core regions
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
BG101876A (en) Hcv genome sequences for diagnostics and treatment
NO972264L (en) Methods of treating multiple sclerosis using peptide analogues of human myelin base protein
NZ319786A (en) HCV NS3 protein fragments with helicase activity and improved solubility
DE69333914D1 (en) METHOD AND COMPOSITIONS FOR CONTROLLING THE TRANSLATION OF HCV PROTEINS
ATE249838T1 (en) PRESERVED MOTIF OF THE HEPATITIS C VIRUS E2/NS1 REGION
FI981381L (en) Method for producing HCV polypeptides
DE69901099D1 (en) USE OF INTERFERON ALPHA 5 IN THE TREATMENT OF VIRAL HEPATOPATHIA

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC.